Specificities of multiple sclerosis cerebrospinal fluid and serum antibodies against mimotopes

Clinical Immunology

Volumn 93, Issue 3, 1999, Pages 283-293

  Jolivet Reynaud, Colette ^a   Perron, Hervé ^a   Ferrante, Pasquale ^b   Becquart, Laurence ^a   Dalbon, Pascal ^a   Mandrand, Bernard ^a  

^a BIOMÉRIEUX   (France)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Antibodies; CSF; Epitopes; Multiple sclerosis; Peptides

Indexed keywords

EPITOPE; PEPTIDE;

AMINO ACID ANALYSIS; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; MULTIPLE SCLEROSIS; PEPTIDE ANALYSIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

EID: 0032763913     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4789     Document Type: Article

References (42)

1. Salmi A., Ziola B., Hovi T., Reunanen M. Antibodies to coronaviruses OC43 and 229E in multiple sclerosis patients. Neurology. 32:1982;292-295.
2. Koprowski K., DeFreitas E. C., Harper M. E., Sandberg W., Sheremata W. A., Robert-Guroff M., Saxinger C. W., Feinberg M. B., Wong-Staal F. Multiple sclerosis and the human T-cell lymphotropic retroviruses. Nature. 318:1985;154-160.
3. Goswami K. K. A., Randall R. E., Lange L. S., Russell W. C. Antibodies against the paramyxovirus SV5 in the cerebrospinal fluids of some multiple sclerosis patients. Nature. 327:1987;244-247.
4. Wucherpfennig K. W., Strominger J. L. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell. 80:1995;695-705.
5. Perron H., Lalande B., Gratacap B., Genoulaz O., Laurent A., Geny C., Mallaret M., Schuller E., Stoebner P., Seigneurin J. M. Isolation of retrovirus from patients with multiple sclerosis. Lancet. 337:1992;862-863.
6. Perron H., Garson J. A., Bedin F., Paranhos-Baccala G., Komurian-Pradel F., Mallet F., Tuke W., Voisset C., Blond J. L., Lalande B., Seigneurin J. M., Mandrand B. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA. 94:1997;7583-7588.
7. Blond J. L., Besème F., Duret L., Bouton O., Bedin F., Perron H., Mandrand B., Mallet F. Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J. Virol. 73:1999;1175-1185.
8. Scott J. K., Smith G. P. Searching for peptide ligands with an epitope library. Science. 249:1990;386-390.
9. Smith G. P., Scott J. K. Libraries of peptides and proteins displayed on filamentous phage. Methods Enzymol. 217:1993;228-257.
10. Cortese R., Felici F., Galfre G., Luzzago A., Monaci P., Nicosia A. Epitope discovery using peptide libraries displayed on phage. Trends Biotechnol. 12:1994;262-267.
11. Burritt J. B., Bond C. W., Doss K. W., Jesaitis A. J. Filamentous phage display of oligopeptide libraries. Anal. Biochem. 238:1996;1-13.
12. Dybwad A., Forre O., Kjeldsen-Kragh J., Natvig J. B., Sioud M. Identification of new B cell epitopes in the sera of rheumatoid arthritis patients using a random nonapeptide library. Eur. J. Immunol. 23:1993;3189-3193.
13. Folgori A., Tafi R., Meola A., Felici F., Galfré G., Cortese R., Monaci P., Nicosia A. A general strategy to identify mimotopes of pathological antigens using only random peptides libraries and human sera. EMBO J. 13:1994;2236-2243.
14. Germaschewski V., Murray K. Identification of polyclonal serum specificities with phage-display libraries. J. Virol. Methods. 58:1996;21-32.
15. Dybwad A., Forre O., Natvig J., Sioud J. M. Structural characterization of peptides that bind synovial fluid antibodies from RA: A novel strategy for identification of disease-related epitopes using a random peptide library. Clin. Immunol. Immunopathol. 75:1995;45-50.
16. Cortese I., Tafi R., Grimaldi L. M. E., Martino G., Nicosia A., Cortese R. Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries. Proc. Natl. Acad. Sci. USA. 93:1996;11063-11067.
17. Cortese I., Capone S., Tafi R., Grimaldi L. M. E., Nicosia A., Cortese R. Identification of peptides binding to IgG in the CSF of Multiple Sclerosis patients. Multiple Sclerosis. 4:1998;31-36.
18. Cortese I., Capone S., Luchetti S., Grimaldi L. M. E., Nicosia A., Cortese R. CSF-enriched antibodies do not share specificities among MS patients. Multiple Sclerosis. 4:1998;118-123.
19. Dybwad A., Forre O., Sioud M. Probing for cerebrospinal fluid antibody specificities by a panel of random peptide libraries. Autoimmunity. 25:1997;85-89.
20. Moulin D., Paty D. W., Ebers G. C. The predictive value of cerebrospinal fluid electrophoresis in "possible" multiple sclerosis. Brain. 106:1983;809-816.
21. Hershey L. A., Trotter J. L. The use and abuse of the cerebrospinal fluid IgG profile in the adult: a practical evaluation. Ann. Neurol. 8:1980;426-434.
22. Blennow K., Fredman P., Wallin A., Gottfries C. G., Frey H., Pirtilâ T., Skoog I., Wikkelö C., Svennerholm L. Formulas for the quantification of intrathecal IgG production. J. Neurol. Sci. 121:1994;90-96.
23. Luxton R. W., Zeman A., Holzel H., Harvey P., Wilson J., Kocen R., Morgan-Hughes J., Miller D. H., Compston A., Thompson E. J. Affinity of antigen-specific IgG distinguishes multiple sclerosis from encephalitis. J. Neurol. Sci. 132:1995;11-19.
24. Tibblings G., Link H., Ohman S. Principles of albumin and IgG analysis in neurological disorders: I. Establishement of reference values. Scand. J. Clin. Lab. Invest. 37:1977;385-390.
25. Link H., Kostulas V. Utility of isoelectric focusing of cerebrospinal fluid and serum on agarose evaluated for neurological patients. Clin. Chem. 29:1983;810-815.
26. Deibel M. R., Lobl T. J., Yem A. W. A technique for rapid purification of low yield products: Biotinylation of chemically synthetized proteins on-resin. Peptide Res. 2:1989;189-194.
27. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1982;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
28. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
29. Ratner L., Haseltime W. W., Patarca R., Livak K. J., Starcich B., Josephs S. F., Doran E. R., Rafalski J. A., Whitehorn E. A., Baumeister K., Ivanoff L., Petteway S. R. Jr., Pearson M. L., Lautenberger J. A., Papas T. S., Ghrayeb J., Chang N. T., Gallo R. C., Wong-Staal F. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature. 313:1985;277-284.
30. Reiber H. Cerebrospinal fluid - Physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Multiple Sclerosis. 4:1998;99-107.
31. Link H., Cruz M., Gessain A., Gout O., de The G., Kham-Hansen S. Chronic progressive myelopathy associated with HTLV-1: Oligoclonal IgG and anti HTLV-1 IgG antibodies in cerebrospinal fluid and serum. Neurology. 39:1989;1566-1572.
32. Vartdal F., Vandvik B., Norrby E. Viral and bacterial antibody responses in multiple sclerosis. Ann. Neurol. 8:1980;248-255.
33. Frederiksen J. L., Sindic C. J. Intrathecal synthesis of virus-specific oligoclonal IgG, and of free kappa and free lambda oligoclonal bands in acute monosymptomatic optic neuritis. Comparison with brain MRI. Multiple Sclerosis. 4:1998;22-26.
34. Katz B. A. Structural and mechanistic determinants of affinity and specificity of ligands discovered or engineered by phage display. Annu. Rev. Biophys. Struct. 26:1997;27-45.
35. Komurian-Pradel F., Paranhos-Baccala G., Bedin F., Ounanian-Paraz A., Sodoyer M., Ott C., Rajoharison A., Garcia E., Mallet F., Mandrand B., Perron H. Molecular cloning and characterization of MSRV-related sequences associated with retrovirus-like particles. Virology. 260:1999;1-9.
36. Oldenburg K. R., Loganathan D., Goldstein I. J., Schultz P. G., Gallop M. A. Peptide ligands for a sugar-binding isolated from a random peptide library. Proc. Natl. Acad. Sci. USA. 89:1992;5393-5397.
37. Luzzago A., Felici F., Tramontano A., Pessi A., Cortese R. Mimicking of discontinuous epitopes by phage-displayed peptides, I. Epitope mapping of human H ferritin using a phage library of constrained peptides. Gene. 128:1993;51-57.
38. Warren K. G., Catz I. Diagnostic value of cerebrospinal fluid anti-myelin basic protein in patients with multiple sclerosis. Ann. Neurol. 20:1986;20-25.
39. Warren K. G., Catz I. Cerebrospinal fluid autoantibodies to myelin basic protein in multiple sclerosis patients. Detection during first exacerbations and kinetics of acute relapse and subsequent convalescent phases. J. Neurol. Sci. 91:1989;143-151.
40. Steinman L., Conlon P. Viral damage and the breakdown of self-tolerance. Nat. Med. 3:1997;1085-1087.
41. Conrad B., Weissmahr R. N., Böni J., Arcari R., Schüpbach J., Mach B. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell. 90:1997;303-313.
42. Garren H., Steinman L., Lock C. The specificity of the antibody response in multiple sclerosis. Ann. Neurol. 43:1998;4-6.